Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Lupin Limited

Equities

LUPIN

INE326A01037

Delayed Bombay S.E.
Other stock markets
 05:48:19 2024-06-10 am EDT 		5-day change 1st Jan Change
1,629 INR -0.03% Intraday chart for Lupin Limited +2.96% +23.26%
Jun. 05 Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada MT
May. 30 India's pharma export sales to grow faster this year, trade body says RE

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada
India's pharma export sales to grow faster this year, trade body says
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection
Lupin Limited Announces Board Appointments
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Lupin Limited Board Recommends Dividend for the Year Ended March 31, 2024
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Lupin Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Lupin Limited Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains
Lupin Limited Announces Launch of Mirabegron Extended-Release Tablets, 25 Mg, in the United States, After Having Received an Approval from the United States Food and Drug Administration
US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US
Lupin Launches Generic Drug for Inflammatory Lesions of Rosacea in US
Lupin Limited Announces the Launch of First Generic Version of Oracea® (Doxycycline Capsules, 40 Mg), in the United States
Indian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate Cuts
Lupin Names Chief Quality Officer
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. News Lupin Limited
  5. Other languages